These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression of L amino acid transport system 1 and analysis of iodine-123-methyltyrosine tumor uptake in a pancreatic xenotransplantation model using fused high-resolution-micro-SPECT-MRI. von Forstner C, Zuhayra M, Ammerpohl O, Zhao Y, Tiwari S, Jansen O, Kalthoff H, Henze E, Egberts JH. Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):30-7. PubMed ID: 21269932 [Abstract] [Full Text] [Related]
4. Transport of D-[1-14C]-amino acids into Chinese hamster ovary (CHO-K1) cells: implications for use of labeled d-amino acids as molecular imaging agents. Shikano N, Nakajima S, Kotani T, Ogura M, Sagara J, Iwamura Y, Yoshimoto M, Kubota N, Ishikawa N, Kawai K. Nucl Med Biol; 2007 Aug; 34(6):659-65. PubMed ID: 17707806 [Abstract] [Full Text] [Related]
8. Developing new molecular imaging probes for PET. Serdons K, Verbruggen A, Bormans GM. Methods; 2009 Jun; 48(2):104-11. PubMed ID: 19318126 [Abstract] [Full Text] [Related]
9. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents. McConathy J, Yu W, Jarkas N, Seo W, Schuster DM, Goodman MM. Med Res Rev; 2012 Jul; 32(4):868-905. PubMed ID: 21793016 [Abstract] [Full Text] [Related]
10. Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection. Martarello L, McConathy J, Camp VM, Malveaux EJ, Simpson NE, Simpson CP, Olson JJ, Bowers GD, Goodman MM. J Med Chem; 2002 May 23; 45(11):2250-9. PubMed ID: 12014963 [Abstract] [Full Text] [Related]
11. Radiolabelled chemotherapeutics. Rottey S, Signore A, Van de Wiele C. Q J Nucl Med Mol Imaging; 2007 Jun 23; 51(2):139-51. PubMed ID: 17420715 [Abstract] [Full Text] [Related]
13. Mass effect of injected dose in small rodent imaging by SPECT and PET. Kung MP, Kung HF. Nucl Med Biol; 2005 Oct 23; 32(7):673-8. PubMed ID: 16243641 [Abstract] [Full Text] [Related]
14. Spectral analysis: principle and clinical applications. Murase K. Ann Nucl Med; 2003 Sep 23; 17(6):427-34. PubMed ID: 14575374 [Abstract] [Full Text] [Related]
17. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Kühl HP, Lipke CS, Krombach GA, Katoh M, Battenberg TF, Nowak B, Heussen N, Buecker A, Schaefer WM. Eur Heart J; 2006 Apr 23; 27(7):846-53. PubMed ID: 16434414 [Abstract] [Full Text] [Related]
18. Synthesis and evaluation of radioiodinated cyclooxygenase-2 inhibitors as potential SPECT tracers for cyclooxygenase-2 expression. Kuge Y, Katada Y, Shimonaka S, Temma T, Kimura H, Kiyono Y, Yokota C, Minematsu K, Seki K, Tamaki N, Ohkura K, Saji H. Nucl Med Biol; 2006 Jan 23; 33(1):21-7. PubMed ID: 16459255 [Abstract] [Full Text] [Related]
20. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer. Wang H, Fu HL, Li JN, Zou RJ, Gu ZH, Wu JC. Clin Imaging; 2009 Jan 23; 33(1):49-54. PubMed ID: 19135930 [Abstract] [Full Text] [Related] Page: [Next] [New Search]